Consensus statement on iron overload in myelodysplastic syndromes

被引:143
|
作者
Bennett, John M. [1 ]
机构
[1] Myelodysplast Syndromes Fdn, Crosswicks, NJ USA
关键词
D O I
10.1002/ajh.21269
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In May 2005 at the 8th International Symposium on Myelodysplastic Syndromes (MDS), a consensus meeting was held on iron overload in MDS (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25). The recommendations of the 2005 consensus meeting were discussed in the context of currently available evidence at the 9th International Symposium on Myelodysplastic Syndromes in Florence Italy, May 2007. The recommendations of the consensus working group are presented here. The recommendations are a continued refinement of the outcome of the 2005 consensus meeting and the ground-breaking work of others in this area (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25; Gattermann, Int J Hematol 2008;88:24-29; Alessandrino et al., Haematologica 2002;87:1286-1306; NCCN practice guidelines: Myelodysplastic Syndromes, version 2.2008). Am. J. Hematol. 83:858-861, 2008. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:858 / 861
页数:4
相关论文
共 50 条
  • [21] RISKS FOR INFECTION IN PATIENTS WITH MYELODYSPLASTIC AND MYELODYSPLASTIC/ MYELOPROLIFERATIVE SYNDROMES: IMPACT OF IRON OVERLOAD
    Orero, M. T.
    Javier, K.
    Villegas, C.
    Costa, S.
    Ortiz, S.
    Perez, P.
    Roig, M.
    Linares, M.
    LEUKEMIA RESEARCH, 2017, 55 : S148 - S149
  • [22] Iron-overload links to genetic instability in myelodysplastic syndromes
    Westhofen, G.
    Ganster, C.
    Beyer, F.
    Rassaf, T.
    Al-Ali, H. K.
    Stuhlmann, R.
    Glass, B.
    Bacher, U.
    Bruemmendorf, T.
    Germing, U.
    Gattermann, N.
    Haase, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 123 - 123
  • [23] Iron overload-induced genetic instability in myelodysplastic syndromes
    Westhofen, G.
    Ganster, C.
    Al-Ali, H. K.
    Haase, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 248 - 249
  • [24] RETROSPECTIVE EVALUATION OF IRON OVERLOAD PREVALENCE IN MYELODYSPLASTIC SYNDROMES AT THE DIAGNOSIS
    Ricerca, B. M.
    Voso, M. T.
    Greco, M.
    Fianchi, L.
    Pagano, L.
    Giordano, G.
    Piano, S.
    Storti, S.
    Leone, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 532 - 532
  • [25] Optimizing Therapy for Iron Overload in the Myelodysplastic Syndromes Recent Developments
    Leitch, Heather A.
    DRUGS, 2011, 71 (02) : 155 - 177
  • [26] PRACTICAL CONSIDERATIONS IN TREATING PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND IRON OVERLOAD
    McKiernan, Phyllis
    Shah, Jayshree
    ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [27] Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes
    Wimazal, F.
    Noesslinger, T.
    Baumgartner, C.
    Sperr, W. R.
    Pfeilstoecker, M.
    Valent, P.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (05) : 406 - 411
  • [28] Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
    Gattermann, Norbert
    LEUKEMIA RESEARCH, 2007, 31 : S10 - S15
  • [29] Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
    Takahiro Suzuki
    Masao Tomonaga
    Yasushi Miyazaki
    Shinji Nakao
    Kazuma Ohyashiki
    Itaru Matsumura
    Yutaka Kohgo
    Yoshiro Niitsu
    Seiji Kojima
    Keiya Ozawa
    International Journal of Hematology, 2008, 88 : 30 - 35
  • [30] Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
    Suzuki, Takahiro
    Tomonaga, Masao
    Miyazaki, Yasushi
    Nakao, Shinji
    Ohyashiki, Kazuma
    Matsumura, Itaru
    Kohgo, Yutaka
    Niitsu, Yoshiro
    Kojima, Seiji
    Ozawa, Keiya
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (01) : 30 - 35